1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Pharmaceutical Excipients Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Pharmaceutical Excipients Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Growing demand for drug formulations
- 5.1.2 Rise in biologic and generic drugs
5.2 Market Opportunities
- 5.2.1 Expansion in pharmaceutical excipients market
- 5.2.2 Growth in oral solid dosage forms
5.3 Future Trends
- 5.3.1 Growth in biopharmaceutical excipients
- 5.3.2 Increasing demand for customized drug delivery systems
5.4 Impact of Drivers and Restraints
6. North America Pharmaceutical Excipients Market Regional Analysis
6.1 North America Pharmaceutical Excipients Market Overview
6.2 North America Pharmaceutical Excipients Market Revenue 2020-2028 (US$ Million)
6.3 North America Pharmaceutical Excipients Market Forecast Analysis
7. North America Pharmaceutical Excipients Market Analysis – by Type
7.1 Bioresorbable Polymers
- 7.1.1 Overview
- 7.1.2 Bioresorbable Polymers: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Lipids and Liposome-Based Formulation
- 7.2.1 Overview
- 7.2.2 Lipids and Liposome-Based Formulation: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Oleochemicals
- 7.3.1 Overview
- 7.3.2 Oleochemicals: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Sugars
- 7.4.1 Overview
- 7.4.2 Sugars: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Cellulose
- 7.5.1 Overview
- 7.5.2 Cellulose: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Starches
- 7.6.1 Overview
- 7.6.2 Starches: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Petrochemicals
- 7.7.1 Overview
- 7.7.2 Petrochemicals: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Plant Proteins and Polyols and Cyclodextrins
- 7.8.1 Overview
- 7.8.2 Plant Proteins and Polyols and Cyclodextrins: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
7.9 Inorganic Chemicals
- 7.9.1 Overview
- 7.9.2 Inorganic Chemicals : North America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
7.10
- 7.10.1 Overview
- 7.10.2 : North America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Pharmaceutical Excipients Market Analysis – by Clinical Indication
8.1 Cancer
- 8.1.1 Overview
- 8.1.2 Cancer: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Metabolic
- 8.2.1 Overview
- 8.2.2 Metabolic: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Infectious Diseases
- 8.3.1 Overview
- 8.3.2 Infectious Diseases: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Dental
- 8.4.1 Overview
- 8.4.2 Dental: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Ophthalmic
- 8.5.1 Overview
- 8.5.2 Ophthalmic: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Gene Therapies
- 8.6.1 Overview
- 8.6.2 Gene Therapies: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Pharmaceutical Excipients Market Analysis – by Functionality
9.1 Coloring Agent and Coating Agent
- 9.1.1 Overview
- 9.1.2 Gene Therapies: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Sweetener and Flavoring Agents
- 9.2.1 Overview
- 9.2.2 Gene Therapies: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Suspending and Viscosity Agents
- 9.3.1 Overview
- 9.3.2 Gene Therapies: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Preservative and Controlled-Release
- 9.4.1 Overview
- 9.4.2 Gene Therapies: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Antioxidant and Oil
- 9.5.1 Overview
- 9.5.2 Gene Therapies: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Tablet Filler and Diluents
- 9.6.1 Overview
- 9.6.2 Gene Therapies: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Binders and Compression Aids and Granulating Agents
- 9.7.1 Overview
- 9.7.2 Gene Therapies: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Pharmaceutical Excipients Market – North America Analysis
10.1 North America
- 10.1.1 North America Pharmaceutical Excipients Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.1.1.1 North America Pharmaceutical Excipients Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 US: North America Pharmaceutical Excipients Market Breakdown, by Type
- 10.1.1.1.2 US: North America Pharmaceutical Excipients Market Breakdown, by Clinical Indication
- 10.1.1.1.3 US: North America Pharmaceutical Excipients Market Breakdown, by Functionality
- 10.1.1.2 Canada:
North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Canada: North America Pharmaceutical Excipients Market Breakdown, by Type
- 10.1.1.2.2 Canada: North America Pharmaceutical Excipients Market Breakdown, by Clinical Indication
- 10.1.1.2.3 Canada: North America Pharmaceutical Excipients Market Breakdown, by Functionality
- 10.1.1.3 Mexico :
North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Mexico : North America Pharmaceutical Excipients Market Breakdown, by Type
- 10.1.1.3.2 Mexico : North America Pharmaceutical Excipients Market Breakdown, by Clinical Indication
- 10.1.1.3.3 Mexico : North America Pharmaceutical Excipients Market Breakdown, by Functionality
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Pharmaceutical Excipients Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Archer-Daniels-Midland Co
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 AshLand Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Avantor Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 BASF SE
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Evonik Industries AG
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 JRS PHARMA GmbH & Co. KG
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 MEGGLE GmbH & Co KG
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Roquette Freres SA
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 The Dow Chemical Co
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 The Lubrizol Corp
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For North America Pharmaceutical Excipients Market
